APP Oncology Summits are developed with and for advanced practice providers including Nurse Practitioners (NPs), Physician Assistants (PAs), Pharmacists (and RNs).
As part of the multidisciplinary team in the care of cancer patients, students, physicians, and other healthcare professionals involved in the management of cancer patients are also welcome to attend.
Students, Fellows, and Industry Employees, see pricing below. Register early to guarantee your spot!
Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession. If you would like to attend as a Student, please contact info@horizoncme.com for further information.
Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc).
Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
Friday, March 14, 2025 | |
| 7:00am | Registration Open & Breakfast Available in Exhibit Hall |
| 8:00am | Horizon CME App Overview |
| 8:05am | Welcome, Introductions, & CE Housekeeping |
| 8:10am | (01A) CAR-T Cell Therapy: The Moving Target of Oncology and Beyond » Meaghan Ekstrom, NP – Hematology, Oncology Nurse Practitioner Cellular Therapy Nurse Practitioner Massachusetts General Hospital |
| 8:55am | (02A) Cancer Survivorship: Care Beyond Diagnosis and Treatment » Abigail Slate Ciampa, MSN, APRN-BC – Nurse Practitioner Adult Survivorship Program Dana-Farber Cancer Institute |
| 9:40am | Break | Refreshments in Exhibit Hall |
| 10:10am | (03) Targeting Soft-Tissue Tumors: Advances in the Management of Desmoid Tumors and TGCT | This activity is supported by an independent medical education grant from SpringWorks Therapeutics Inc. » Candace Haddox, MD – Medical Oncology Dana-Farber Cancer Institute |
| 11:10am | (04A) Getting into the Weeds: A Comprehensive Guide to the Benefits, Risks, and Evidence for Cannabis in the Oncology setting » Daniel S. Glidden, MS, PA-C – Integrative Oncology Physician Assistant The Leonard P. Zakim Center for Integrative Therapies & Healthy Living Dana-Farber Cancer Institute |
| 11:55am | Gather Lunch |
| 12:00pm | #1 Buffet Lunch & Non-CME/CE Presentation Sponsored by AbbVie: Exploring Treatment Data for CLL with a BCL2i•Diving Deep into BCL2i Fixed Treatment Regimens in CLL » MELISSA LARAMIE MSN, APRN, CLNC, OCN #2 Buffet Lunch & Non-CME/CE Presentation Sponsored by AstraZeneca: Clinical Insights From Adapted Patient Cases: The Journey From Diagnosis Through CALQUENCE Treatment » Laura Mulka, MSN, APRN, ANP-C, AOCN, ACHPN – University of Connecticut School of Nursing Starling Physicians |
| 12:45pm | After Lunch Dessert Break in Exhibit |
| 1:00pm | (05) Ongoing Advances in Cancer Drug Therapy: New Agents, Expanded Indications, and Strategies for Optimizing Treatment » Sydney Smith, PharmD, BCOP – Clinical Pharmacy Specialist Breast Oncology Dana-Farber Cancer Institute |
| 1:45pm | (06A) Managing fear and insomnia in cancer survivors: Evidence-based techniques for your patients » Daniel Hall, PhD – Psychiatric Oncology and Behavioral Sciences Psychiatry Mass General Psychology |
| 2:30pm | Message from the Charities |
| 2:45pm | Trivia for Charity Break in Exhibit Hall |
| 3:05pm | (07A) “APP, put an APB on the NGS !” How to achieve best outcomes for your patients with lung cancer in 2025 » Christopher G. Azzoli, MD – Director of Thoracic Oncology Associate Professor of Medicine Brown University Health Cancer Institute (07B) Immune Thrombocytopenia (ITP) Disease Overview and Review of Current Management » Inna Yakirevich, NP – Nurse Practitioner Hematology and Oncology Brown University Health Cancer Institute |
| 3:50pm | Network Reception |
| 6:30pm | Dinner invite sponsored by TBA |
Saturday, March 15, 2025 | |
| 7:00am | Check-in & Exhibit Hall Open |
| 7:30am | Horizon CME APP Overview |
| 7:35am | Welcome, Introductions, & CE Housekeeping |
| 7:50Am | (08A) Sickle Cell Disease: Optimizing Outcomes through Equitable Care » Patrick Thomas McGann, MD, PhD – Director of Hemoglobinopathies Program Pediatrics Hasbro Children’s Hospital Brown University Health Cancer Institute |
| 8:40am | Gather for Breakfast |
| 8:45am | #1 Morning Breakfast Buffet sponsored by Pfizer Oncology: Supporting Patients With HR+/HER2- mBC Throughout Their Treatment Journey » Kristi Orbaugh, RN, MSN, RNP, AOCN #2 Morning Breakfast Buffet sponsored by Sumitomo: A GnRH Antagonist Treatment Option for Advanced Prostate Cancer » Nazy Zomorodian, MSN, CUNP – Adj Assistant Professor David Geffen School of Medicine Director, GU Clinical Trials Program Institute of Urologic Oncology at UCLA |
| 9:35am | Transition Break |
| 9:40am | (09A) Palliative Care and Pain Management for Patients with Cancer » Dana L. Guyer, MD – Palliative Care Physician Director of Supportive Care Hospice and Palliative Medicine Brown University Health Cancer Institute |
| 10:25am | Break – Refreshments in Exhibit Hall |
| 11:00am | (10A) Striking a Balance: Managing Immunotherapy-related AKI » Harish Shanthanu Seethapathy, MD – Nephrology Assistant Physician Instructor Harvard Medical School MGH Department of Medicine |
| 11:45am | (11A) Personalized Cancer Therapy in Precision Medicine: The Expanding Role of Pharmacogenomics in Oncology » Leila Rostamnjad, PharmD, BCOP – Manager of Clinical Pharmacy Services Solid Tumor Clinical Pharmacy Specialist of Thoracic Oncology and Symptom Management Dana- Farber Cancer Insitute |
| 12:30pm | Gather Lunch |
| 12:35pm | Buffet Lunch & Non-CME/CE Presentation Sponsored by Amgen- Breakthrough Innovation: The First and Only Bispecific T-cell Engager (BiTE®) Therapy for 2L+ Extensive-Stage Small Cell Lung Cancer (ES-SCLC) » Marina Barsoum, PharmD, BCOP |
| 1:20pm | Dessert Break in Exhibit Hall |
| 1:35pm | (12A) Myeloma Bispecifics: Double Trouble » Shahrier Hossain, PharmD, BCOP – Clinical Pharmacy Specialist Myeloma Dana-Farber Cancer Institute |
| 2:20pm | (13A) Tumor Board: Breast » Sabrina Witherby, MD – Breast Oncologist Hematologist-Oncologist Brown Health Cancer Institute » Allegra Bernardo Matook, MPAS, PA-C – Breast and Gynecologic Malignancies Brown University Health Cancer Institute Rhode Island Hospital » Gillian Serino, DNP, FNP-BC, AOCNP – Oncology Certified Nurse Practitioner Director of Advanced Practice Nursing Breast Oncology Center Dana-Farber Cancer Institute » Jennifer A McKenna, MSN, AOCNP – Acute Care Nurse Practitioner Breast Oncology Center Dana-Farber Cancer Institute |
| 3:20pm | Closing Remarks |
The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This conference is approved for up to 10.00 credit by the Washington State Pharmacy Association.
This activity is approved for up to 10.00 credit by the Washington State Pharmacy Association. ACPE#: 0130-9999-21–L01-P | Activity Type: Live| Start/End date: Fri, 03/14/2025 – 4:00am-Sat, 03/15/2025 – 12:00pm The Washington State Pharmacy Association (WSPA) is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. NOTE FOR PHARMACISTS: It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP eProfile ID and DOB (in MMDD format)] within the evaluation, in order to receive credit for participating in this CPE activity. Following the activity’s end date, there is a maximum of 60 days allowed to upload the CPE information to the CPE Monitor. WSPA will upload the CPE information to the CPE monitor 50 days after the activity – please check your CPE Monitor at this time to ensure the CPE is uploaded in your profile. If you encounter any CPE problems, please contact WSPA at 425- 228-7171
Attention Pharmacists: Earn CE credit toward your BCOP recertification*
Horizon CME is proud to support the recertification of oncology pharmacists and the new BPS pilot program for continuing professional development. For program details, please go here.
The APP Oncology Summit is a two-day conference designed to provide advanced practice providers (APPs) with the latest evidence-based strategies to optimize care and outcomes for patients with cancer. This conference is planned with and for advanced practice providers (NPs, PAs, pharmacists, and nurse specialists) and is a collaborative effort of oncology clinicians from multiple organizations in each community.
The APP Oncology Summit offers a unique opportunity for APPs from various healthcare teams in the community to collaborate, learn from each other and national faculty, and share best practices on a range of issues related to the care of cancer patients.
APP Oncology Summits are developed with and for advanced practice providers including NPs, PAs, pharmacists, and nurses.
As part of the multidisciplinary team in the care of cancer patients, students, physicians, and other healthcare professionals involved in the management of cancer patients are also welcome to attend.
NP Ambulatory Oncology APP Manager Massachusetts General Hospital
Nurse Practitioner, Hematology/Oncology Tufts Medical Center
Nurse Practitioner Brown University Health Cancer Institute Providence, RI
Clinical Pharmacy Manager Solid Tumors Dana-Farber Cancer Institute Boston, MA
Chief Nurse Practioner Dana-Farber Cancer Institute Boston, MA
Lindley M.
We want to ensure that your time at the 2025 APPOS Boston conference is convenient and memorable. Staying at our host hotel provides a hassle-free experience and puts you at the heart of the activity surrounding the conference.
Overnight Accommodations: Discounted booking closes on: Reservations must be received on or before February 14, 2025
Dates for discounted rates: March 13-14, 2025
Click here to book your room today!
Room rate: TBA
Parking: TBA
Disclaimer:
All reservations must be booked using the link above before the closing date listed. Overnight accommodation, parking, and resort fees will revert back to standard hotel pricing outside of the dates above. A set number of rooms have been blocked off for the discounted pricing. If all of those rooms have already been booked, discounted pricing may not be available for additional rooms or accommodations.